..........Given the above-illustrated opinion conflicts, with a 10-fold variation in dose and a six-fold variation in timing interval, a search through published sources was conducted, mirroring a wide range of combinations regarding recommendations for both the PRN narcotic doses and the appropriate intervals at which they should be repeated in the event of continued pain. Data from 22 review articles and texts that review guidelines for the treatment of cancer pain, presented in Table 3, 1-22 provided a 20-fold variation in recommended narcotic doses (1% to 20% of daily doses) along with scattered opinions, or no direction, regarding appropriate dose intervals for potential repeat doses...............
.............Specific guidelines for prescribing opioids are needed to allow
practitioners to feel comfortable in administering these medications.
These guidelines must include how to determine the
appropriate dose for breakthrough pain, and the appropriate and safe
interval
that will allow for rapid pain relief, but maintain
patient safety. On completion of this project, the 2004 National
Comprehensive
Cancer Network guidelines for cancer pain were
found.27
These guidelines come to similar conclusions that recommend the use of
intravenous narcotic doses of 10% to 20% of the daily
intravenous morphine equivalent and the use of
repeat doses at 15-minute intervals, if pain is still present. The
information
from this project might be used to facilitate
continuous-improvement projects at individual institutions. Such a
project is
in process locally. The incorporation of this new
information regarding PRN narcotic use should better serve the needs of
patients.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.